approved EB-2 (NIW)

Postdoctoral Associate

Molecular Biology · India · 2022-04-11

Processing Time
173 days
Decision Date
2022-04-11
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to systematically characterize genes and pathways involved in cancer development and progression using laboratory-based and animal models to study biological and clinical phenotypes. This work aims to identify novel molecular targets for cancer diagnosis, prognosis, and treatment modalities, specifically focusing on advanced breast cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor is of great importance due to its value in the global fight against cancer and its specific implications for U.S. treatment strategies for advanced breast cancer.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her academic productivity, including 7 publications, 279 citations, and leadership roles on editorial boards.

3 Waiver of Job Offer and Labor Certification Met

The petition was approved, implying that on balance, it is beneficial to the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The case was approved based on the petitioner's record of 7 peer-reviewed journal articles and 279 citations, demonstrating significant impact. She also completed 60 peer reviews and served on the editorial boards of several international journals, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 173 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist